Ricci, M.; Cimini, A.; Camedda, R.; Chiaravalloti, A.; Schillaci, O.
Tau Biomarkers in Dementia: Positron Emission Tomography Radiopharmaceuticals in Tauopathy Assessment and Future Perspective. Int. J. Mol. Sci. 2021, 22, 13002.
https://doi.org/10.3390/ijms222313002
AMA Style
Ricci M, Cimini A, Camedda R, Chiaravalloti A, Schillaci O.
Tau Biomarkers in Dementia: Positron Emission Tomography Radiopharmaceuticals in Tauopathy Assessment and Future Perspective. International Journal of Molecular Sciences. 2021; 22(23):13002.
https://doi.org/10.3390/ijms222313002
Chicago/Turabian Style
Ricci, Maria, Andrea Cimini, Riccardo Camedda, Agostino Chiaravalloti, and Orazio Schillaci.
2021. "Tau Biomarkers in Dementia: Positron Emission Tomography Radiopharmaceuticals in Tauopathy Assessment and Future Perspective" International Journal of Molecular Sciences 22, no. 23: 13002.
https://doi.org/10.3390/ijms222313002
APA Style
Ricci, M., Cimini, A., Camedda, R., Chiaravalloti, A., & Schillaci, O.
(2021). Tau Biomarkers in Dementia: Positron Emission Tomography Radiopharmaceuticals in Tauopathy Assessment and Future Perspective. International Journal of Molecular Sciences, 22(23), 13002.
https://doi.org/10.3390/ijms222313002